11-125956970-G-C

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001378964.1(CDON):​c.*3972C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00855 in 622,258 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.0068 ( 8 hom., cov: 33)
Exomes 𝑓: 0.0091 ( 22 hom. )

Consequence

CDON
NM_001378964.1 3_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.318

Publications

2 publications found
Variant links:
Genes affected
CDON (HGNC:17104): (cell adhesion associated, oncogene regulated) This gene encodes a cell surface receptor that is a member of the immunoglobulin superfamily. The encoded protein contains three fibronectin type III domains and five immunoglobulin-like C2-type domains. This protein is a member of a cell-surface receptor complex that mediates cell-cell interactions between muscle precursor cells and positively regulates myogenesis. [provided by RefSeq, Aug 2011]
VSIG10L2 (HGNC:27879): (V-set and immunoglobulin domain containing 10 like 2) Predicted to enable cell adhesion molecule binding activity. Predicted to be involved in cell-cell adhesion. Predicted to be active in cell-cell junction. Predicted to be integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BS2
High AC in GnomAd4 at 1041 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDONNM_001378964.1 linkc.*3972C>G 3_prime_UTR_variant Exon 20 of 20 ENST00000531738.6 NP_001365893.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDONENST00000531738.6 linkc.*3972C>G 3_prime_UTR_variant Exon 20 of 20 1 NM_001378964.1 ENSP00000432901.2 Q4KMG0-2E9PN78

Frequencies

GnomAD3 genomes
AF:
0.00684
AC:
1041
AN:
152228
Hom.:
8
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00186
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00916
Gnomad ASJ
AF:
0.00778
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00103
Gnomad FIN
AF:
0.00631
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0105
Gnomad OTH
AF:
0.00383
GnomAD4 exome
AF:
0.00911
AC:
4281
AN:
469912
Hom.:
22
Cov.:
6
AF XY:
0.00954
AC XY:
2106
AN XY:
220840
show subpopulations
African (AFR)
AF:
0.00185
AC:
16
AN:
8672
American (AMR)
AF:
0.00180
AC:
1
AN:
556
Ashkenazi Jewish (ASJ)
AF:
0.00603
AC:
17
AN:
2818
East Asian (EAS)
AF:
0.00
AC:
0
AN:
1876
South Asian (SAS)
AF:
0.00130
AC:
12
AN:
9234
European-Finnish (FIN)
AF:
0.00667
AC:
1
AN:
150
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
938
European-Non Finnish (NFE)
AF:
0.00956
AC:
4115
AN:
430374
Other (OTH)
AF:
0.00778
AC:
119
AN:
15294
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
199
397
596
794
993
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
210
420
630
840
1050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00683
AC:
1041
AN:
152346
Hom.:
8
Cov.:
33
AF XY:
0.00671
AC XY:
500
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.00185
AC:
77
AN:
41588
American (AMR)
AF:
0.00915
AC:
140
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00778
AC:
27
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00103
AC:
5
AN:
4832
European-Finnish (FIN)
AF:
0.00631
AC:
67
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0105
AC:
716
AN:
68026
Other (OTH)
AF:
0.00379
AC:
8
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
50
100
150
200
250
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00576
Hom.:
1
Bravo
AF:
0.00650
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Holoprosencephaly 11 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.84
DANN
Benign
0.61
PhyloP100
-0.32
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142923654; hg19: chr11-125826865; API